Why the study?
Does aligning antihypertensive medication dosing time with patient chronotype reduce non-fatal myocardial infarction or stroke in patients with arterial hypertension?
Does aligning antihypertensive medication dosing time with patient chronotype reduce non-fatal myocardial infarction or stroke in patients with arterial hypertension?
Answers are grounded in this paper and cite their sources.
This commentary highlights proof-of-concept evidence from the TIME Chronotype sub-study suggesting that aligning antihypertensive medication dosing time with a patient's endogenous chronotype may reduce the risk of non-fatal myocardial infarction.
Hypertension is the dominant risk factor for cardiovascular pathologies, yet it remains poorly controlled. Chronotherapy, an approach considering circadian (i.e., ∼24-h) rhythms in physiology and pathology, could contribute additional benefit to hypertension management.
No takes yet. Share an insight, caveat, or question.
Baka et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: